Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review
Cancer is a group of disorders characterized by aberrant gene function and alterations in gene expression patterns. In 2020, it was anticipated that 19 million new cancer cases would be diagnosed globally, with around 10 million cancer deaths. Late diagnosis and interventions are the leading causes...
Main Author: | Yosif Almoshari |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/3/600 |
Similar Items
-
Novel pH-Responsive Cubosome and Hexosome Lipid Nanocarriers of SN-38 Are Prospective for Cancer Therapy
by: Sarigama Rajesh, et al.
Published: (2022-10-01) -
A Versatile Nanocarrier—Cubosomes, Characterization, and Applications
by: Cristiana Oliveira, et al.
Published: (2022-06-01) -
Fabrication and Assessment of Orodispersible Tablets Loaded with Cubosomes for the Improved Anticancer Activity of Simvastatin against the MDA-MB-231 Breast Cancer Cell Line
by: Randa Mohammed Zaki, et al.
Published: (2023-04-01) -
Cubosomes in Drug Delivery—A Comprehensive Review on Its Structural Components, Preparation Techniques and Therapeutic Applications
by: Durgaramani Sivadasan, et al.
Published: (2023-04-01) -
Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon Cancer
by: Ahmed A. El-Shenawy, et al.
Published: (2023-02-01)